Stryker (SYK) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
SYK Stock Falls Despite Q1 Earnings & Sales Beat on Lower '25 EPS View
SYK's first-quarter results reflect strong segmental performance, along with a rise in operating margin.
Stryker Corporation (SYK) Q1 2025 Earnings Call Transcript
Stryker Corporation (NYSE:SYK ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Jason Beach - Vice President, Finance and Investor Relations Preston Wells - Vice President, Chief Financial Officer Conference Call Participants Marcus Robert - JPMorgan Larry Biegelsen - Wells Fargo Joanne Wuensch - Citi Ryan Zimmerman - BTIG Travis Steed - Bank of America Vijay Kumar - Evercore ISI David Roman - Goldman Sachs Philip Chickering - Deutsche Bank Matthew Miksic - Barclays Patrick Wood - Morgan Stanley Shagun Singh - RBC Mike Matson - Needham & Company Caitlin Cronin - Canaccord Genuity Danielle Antalffy - UBS Matt Taylor - Jefferies Operator Welcome to the First Quarter 2025 Stryker Earnings Call. My name is Luke and I'll be your operator for today's call.
Stryker (SYK) Surpasses Q1 Earnings and Revenue Estimates
Stryker (SYK) came out with quarterly earnings of $2.84 per share, beating the Zacks Consensus Estimate of $2.73 per share. This compares to earnings of $2.50 per share a year ago.
Strong Segmental Performance to Drive Stryker's Q1 Earnings?
SYK's first-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Gear Up for Stryker (SYK) Q1 Earnings: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Stryker (SYK) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Stryker (SYK) Reports Next Week: Wall Street Expects Earnings Growth
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stryker Unveils Next-Generation Mako SmartRobotics but Stock Falls
SYK unveils next-gen Mako SmartRobotics, revolutionizing hip, knee and spine surgeries with greater precision and first-to-market robotic hip revision technology.
SYK Stock Declines Despite Steri-Shield Launch to Boost OR Portfolio
Stryker launches Steri-Shield 8, a cutting-edge PPE system with enhanced fit, visibility and protection, reinforcing its leadership in medical safety.
SYK Stock Gains on Launch of Hands-Free Device: Sync Badge
Stryker's Sunc Badge is a Hands-free, wearable communication device that will support care team members with fast and reliable collaboration. It is likely to help offset the ongoing nurse shortage.
Stryker Corporation (SYK) Citi's 2025 Unplugged Medtech and Life Sciences Access Day (Transcript)
Stryker Corporation (NYSE:SYK ) Citi's 2025 Unplugged Medtech and Life Sciences Access Day February 27, 2025 12:15 PM ET Company Participants Preston Wells - CFO Jason Beach - VP, Finance, IR Conference Call Participants Joanne Wuensch - Citigroup Joanne Wuensch Joanne Wuensch, the medical technology analyst here at Citi Bank. So for our next session, I'm quite thrilled to have the incoming CFO, Preston Wells and Jason Beach, which I think people know quite well.
SYK Trades Below 52-Week High: Should You Buy, Hold or Sell the Stock?
Stryker is gaining momentum with strong Q4 results, innovative medtech solutions and high-growth market expansion. But, is the stock still a buy?
